Illumina Q2 2016 Financial Results Earnings

Illumina reported Q2 2016 revenue of $600 million, up 11% year-over-year, driven by strength in sequencing consumables and microarray products. Non-GAAP EPS of $0.86 exceeded expectations, though operating margin contracted 480 basis points due to increased investments in headcount, GRAIL, and Helix initiatives.